原始淀粉微粒对接种卡介苗并攻击结核分枝杆菌的小鼠具有免疫刺激活性
研究探索淀粉微粒(SMPs)及固定于其上的结核分枝杆菌热休克蛋白α-晶状体蛋白(μAcr-SBDtag)经鼻加强免疫对卡介苗(BCG)接种小鼠的免疫刺激作用。BALB/c小鼠经气管攻击中等毒力或高毒力结核分枝杆菌后,无论给予固定抗原还是单独SMPs,肺部细菌载量均较仅接种BCG组显著降低,且两加强组间无差异,组织学显示加强免疫未促进肺炎进展。作者认为该系统或可作为黏膜疫苗的碳水化合物佐剂。
要点
- SMPs或μAcr-SBDtag经鼻加强BCG接种小鼠,肺部细菌载量较仅BCG组显著降低。
- 两加强组间肺部细菌载量无差异,提示效应主要来自淀粉。
- 组织学显示加强免疫未促进肺炎进展,降低鼻内给予SMPs的安全性担忧。
核心结论
- 研究提示该系统或可考虑作为针对结核病及其他传染病的黏膜疫苗的新型碳水化合物佐剂。
- 研究凸显颗粒性α-葡聚糖作为免疫应答调节剂的潜力。
研究设计与样本
- 使用BALB/c小鼠进行进行性肺结核(PPT)实验,以SMPs或固定于SMPs的结核分枝杆菌热休克蛋白α-晶状体蛋白(μAcr-SBDtag)经鼻加强BCG接种小鼠,不额外添加佐剂。
- 小鼠经气管攻击中等毒力或高毒力结核分枝杆菌菌株。
主要发现
- 给予固定抗原或SMPs作为BCG加强免疫均诱导小鼠肺部细菌载量显著降低,甚至低于仅接受BCG接种的小鼠。
- 两加强组间肺部细菌载量无差异,所得效应最可能主要由淀粉引起。
- 组织学研究显示给予加强免疫未促进肺炎进展,降低了鼻内给予SMPs相关的安全性担忧。
临床怎么用
- 作者认为该系统或可考虑作为针对结核病及其他传染病的黏膜疫苗的新型碳水化合物佐剂。
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The main challenge for vaccine development or improvement is the lack of safe adjuvants or immunostimulants that induce protective immune responses and can be used for mucosal immunization, which is a highly desirable strategy for vaccination against infectious diseases acquired by oral or intranasal routes. One promising alternative is the use of biodegradable and biocompatible polymeric microparticles. Recently, we developed an immobilization and delivery system with starch microparticles (SMPs) and a starch-binding domain (SBDtag) suitable for the mucosal administration of antigens and the induction of antigen-specific immune responses. Here, we explore the immunostimulant and reinforcing potential of the system using BALB/c mice with progressive pulmonary tuberculosis (PPT). The heat shock protein alpha-crystallin from Mycobacterium tuberculosis immobilized on SMPs (µAcr-SBDtag) or SMPs alone were administered nasally as boosters to BCG-vaccinated mice without any extra adjuvant. The mice were challenged intratracheally with either moderately virulent or highly virulent M. tuberculosis strains. Our results showed that the administration of either the immobilized antigen or SMPs asa booster for the BCG vaccination induced a significant reduction of bacterial loads in the lungs of mice, even more than in mice that received the BCG vaccination alone. Since no difference was observed in pulmonary bacillary burdens between the two reinforced groups, the obtained effect was most likely primarily caused by the starch. As determined by histological study, the administration of boosters did not contribute to the progress of pneumonia, which diminishes the safety concerns related to the administration of SMPs intranasally. Taken together, our findings suggest that this system may be considered asa new carbohydrate-based adjuvant suitable for mucosal vaccines against tuberculosis and other infectious diseases, and more generally, they highlight the potential of particulate α-glucans as immune response modifiers.
引用
- Moreno-Mendieta S, Barrios-Payán J, Mata-Espinosa D, et al. Raw starch microparticles have immunostimulant activity in mice vaccinated with BCG and challenged with Mycobacterium tuberculosis. Vaccine. 2017. PMID: 28818565. doi:10.1016/j.vaccine.2017.08.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。